Article

Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase

Department of Chemistry, Faculty of Mathematics and Natural Science, University of Indonesia, Depok 16424 Indonesia.
Bioinformation (Impact Factor: 0.5). 04/2012; 8(8):348-52. DOI: 10.6026/97320630008348
Source: PubMed

ABSTRACT NS5 methyltransferase (Mtase) has a crucial role in the replication of dengue virus. There are two active sites on NS5 Mtase i.e.,
SAM and RNA-cap binding sites. Inhibition of the NS5 Mtase activity is expected to prevent the propagation of dengue virus. This
study was conducted to design cyclic peptide ligands as enzyme inhibitors of dengue virus NS5 Mtase through computational
approach. Cyclopentapeptides were designed as ligand of SAM binding site as much as 1635 and 736 cyclopentpeptides were
designed as ligand of RNA-cap binding site. Interaction between ligand and NS5 Mtase has been conducted on the Docking
simulation. The result shows that cyclopentapeptide CTWYC was the best peptide candidate on SAM binding site, with estimated
free binding energy -30.72 kca/mol. Cyclopentapeptide CYEFC was the best peptide on RNA-cap binding site with estimated free
binding energy -22.89 kcal/mol. Both peptides did not have tendency toward toxicity properties. So it is expected that both
CTWYC and CYEFC ligands could be used as a potential antiviral drug candidates, which can inhibit the SAM and RNA-cap
binding sites of dengue virus NS5 Mtase.

Download full-text

Full-text

Available from: Usman Sumo Friend Tambunan, Jun 30, 2015
4 Followers
 · 
154 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Background: Dengue hemorrhagic fever is a mosquito-borne, re-emerging infectious disease in many areas of the world, which affects 50 to 100 million human and causes 24,000 deaths every year. Currently, no specific drug is available for dengue fever. Dengue fever is caused by Flavivirus. Methyl transferase (MTase) is particularly important for viral replication, which also plays a key role in normal physiology and human infection through methylating DNA. The flaviviral MTase (NS5) which catalyzes both guanine N-7 and ribose 2`-OH methylation during viral cap formation, serve as a promising flavivirus drug target. The present work is to identify lead molecules for Flavivirus NS5 MTase using computational approaches like structure based pharmacophore and induced fit docking. Methods: Energy-optimized pharmacophore models were generated for the RTP, SAH and SAM ligands based on their binding mode at the different parts of the active site of MTase. Pharmacophore based screening of the Asinex database was performed. The short-listed compounds were subjected for induced fit docking. Results The pharmacophore sites were predicted for RTP, SAH and SAM with seven features of which, minimum of three pharmacophore features were taken as the basis for screening the ligands. At the end of docking analysis, three compounds having high binding capability for RTP, SAH and SAM binding sites of MTase were observed. Conclusions These results suggest that the selected compounds could be novel leads to inhibit MTase and may stop viral replication further. Also, these three lead compounds could be serving as building blocks for designing drug-like molecules for the treatment of dengue hemorrhagic fever.
    Journal of Pharmacy Research 02/2013; 7(1):121-126. DOI:10.1016/j.jopr.2013.01.016 · 0.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Disrupting the interaction between the PDZ protein, PSD-95, and its target ligands (such as the glutamate NMDA receptor or the serotonin 5-HT2A receptor) was found to reduce hyperalgesia in various models of neuropathic pain. Here, we set out to identify lead molecules which would interact with PSD-95, and hence, would potentially display analgesic activity. We describe the virtual screening of the Asinex and Cambridge databases which together contain almost one million molecules. Using three successive docking filters and visual inspection, we identified three structural classes of molecules and synthesized a potential lead compound from each class. The binding of the molecules with the PDZ domains of PSD-95 was assessed by (1)H-(15)N HSQC NMR experiments. The analgesic activity of the best ligand, quinoline 2, was evaluated in vivo in a model of neuropathic pain and showed promising results.
    Bioorganic & medicinal chemistry letters 03/2013; 23(9). DOI:10.1016/j.bmcl.2013.02.100 · 2.33 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dengue has become a major global health threat, especially in tropical and subtropical regions. The development of antiviral agent targeting viral replication is really needed at this time. NS5 methyltransferase presents as a novel antiviral target. This enzyme plays an important role in the methylation of 5'-cap mRNA. Inhibition of the NS5 methyltransferase could inhibit dengue virus replication. In this research, two sites of NS5 methyltransferase (S-Adenosyl methionine/SAM binding site and RNA-cap site) were used as targets for inhibition. As much as 300 commercial cyclic peptides were screened to these target sites by means of molecular docking. Analysis of ligand-enzyme binding free energy and pharmacological prediction revealed two best ligands, namely [Tyr123] Prepro Endothelin (110-130), amide, human and Urotensin II, human. According to molecular dynamic simulation, both ligands maintain a stable complex conformation between enzyme and ligand at temperature 310 K and 312 K. Hence, Urotensin II, human is more reactive at 312 K than at 310 K. However, both ligands can be used as potential inhibitor candidates against NS5 methyltransferase of dengue virus with Urotensin II, human exposes more promising activity at 312 K.
    Bioinformation 01/2014; 10(1):23-7. DOI:10.6026/97320630010023 · 0.50 Impact Factor